SCHEMBL6530144

SCHEMBL6530144

COc1ccc(Cn2cnc(C)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.51
CDK5R1 Q15078 1/20 0.51
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP19A1 P11511 1/20 0.49
QPCT Q16769 1/20 0.48
KDM4C Q9H3R0 1/20 0.46
KDM5B Q9UGL1 1/20 0.46
CMA1 P23946 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HSP90AA1 P07900 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP11B1 P15538 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27744436 0.83 CDK5 (0.51) CDK5CDK5R1MAPTKDM4EALDH1A1
SCHEMBL2979842 0.82 CDK5 (0.50) CDK5CDK5R1MAPTKDM4EALDH1A1
SCHEMBL7510401 0.82 CDK5 (0.50) CDK5CDK5R1MAPTKDM4EALDH1A1
SCHEMBL6530135 0.82 CDK5 (0.50) CDK5CDK5R1MAPTKDM4EALDH1A1
SCHEMBL15707234 0.82 CDK5 (0.50) CDK5CDK5R1MAPTKDM4EALDH1A1
SCHEMBL6528482 0.81 LPO (0.52) MAPTKDM4EALDH1A1CMA1GAA
SCHEMBL6531587 0.81 PHF8 (0.51) MAPTKDM4EALDH1A1CYP19A1KDM4C
SCHEMBL5761329 0.81 CYP11B1 (0.54) CDK5CDK5R1MAPTALDH1A1KDM4C
SCHEMBL4837186 0.79 CYP11B1 (0.50) ALDH1A1CYP19A1GAAGFERCYP11B1
SCHEMBL25583830 0.79 CYP11B1 (0.50) CYP19A1QPCTKDM4CKDM5BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2022082009-A1 INHALED FORMULATIONS OF PGDH INHIBITORS AND METHODS OF USE THEREOF EPIRIUM BIO INC. (US) 2022-04-21 WO disclosed
WO-2021151014-A1 PGDH INHIBITORS AND METHODS OF MAKING AND USING MYOFORTE THERAPEUTICS, INC. (US) 2021-07-29 WO disclosed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed